Showing results (21-30 of 374) with videos related to
Sort By:
Pageof 38
Drug Discovery Today|November 19, 2020
Development and economic trends in anticancer drugs licensed in the UK from 2015 to 2019Mark P Lythgoe, Jonathan Krell, Sarah Mahmoud, et al.BMJ Oncology|January 31, 2025
As bleak as it sounds? Analysing trends in oncology clinical trial initiation in the UK from 2010 to 2022Alexander David VanHelene, Matthew J Hadfield, Dario Trapani, et al.Pharmacology & Therapeutics|May 3, 2016
Why drugs fail in clinical trials in pulmonary arterial hypertension, and strategies to succeed in the futureMark P Lythgoe, Christopher J Rhodes, Pavandeep Ghataorhe, et al.Journal of Clinical Pathology|June 29, 2021
Gene of the month: lymphocyte-activation gene 3 (LAG-3)Mark P Lythgoe, Daniel Si Kit Liu, Nicola E Annels, et al.Public Health Genomics|November 12, 2015
Personalised and Precision Medicine in Cancer Clinical Trials: Panacea for Progress or Pandora's Box?Mark Lawler, Richard SullivanThe International Journal on Drug Policy|March 5, 2013
The role of child protection in cannabis grow-operationsJanet Douglas, Richard SullivanThe New Bioethics : a Multidisciplinary Journal of Biotechnology and the Body|May 19, 2017
Economics of Cancer Medicines: For Whose Benefit?Bishal Gyawali, Richard SullivanEcancermedicalscience|June 10, 2017
Tobacco in post-conflict settings: the case of IraqZainab Hussain, Richard SullivanEcancermedicalscience|August 3, 2023
The reality of cancer care for manyRichard Sullivan, Eduardo CazapMolecular Oncology|January 11, 2019
Mission-oriented translational cancer research - health economicsBengt Jönsson, Richard SullivanPageof 38